CN Patent

CN108026075B — 普那布林组合物

Assigned to DALIAN WANCHUN BIOTECHNOLOGY Co Ltd · Expires 2021-06-29 · 5y expired

What this patent protects

本文公开了普那布林多晶型物、组合物、它们作为治疗剂的用途和制备。特别地，一些实施方案涉及结晶形式的普那布林一水合物。

USPTO Abstract

本文公开了普那布林多晶型物、组合物、它们作为治疗剂的用途和制备。特别地，一些实施方案涉及结晶形式的普那布林一水合物。

Drugs covered by this patent

deuruxolitinib-phosphate (DEURUXOLITINIB PHOSPHATE)

Patent Metadata

Patent number: CN108026075B
Jurisdiction: CN
Classification: —
Expires: 2021-06-29
Drug substance claim: No
Drug product claim: No
Assignee: DALIAN WANCHUN BIOTECHNOLOGY Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.